NP_HORIZONTAL_CMYK (002).png
Northland Power releases 2023 Sustainability Report highlighting ESG achievements
April 29, 2024 07:10 ET | Northland Power Inc.
TORONTO, April 29, 2024 (GLOBE NEWSWIRE) -- Northland Power Inc. (“Northland” or the “Company”) (TSX: NPI) today released its 2023 Sustainability Report, ‘Powering Possibility’, that highlights the...
NVRO.JPG
EnviroGold Global Launches Private Placement and Announces Engagement with Sequoia Corporate Finance Pty Ltd
April 29, 2024 07:07 ET | EnviroGold Global Limited
TORONTO, April 29, 2024 (GLOBE NEWSWIRE) -- EnviroGold Global Limited (CSE: NVRO | OTCQB: ESGLF | FSE: YGK) (“EnviroGold,” or the “Company”), a technology company enabling the global mining industry...
KBLB logo.jpg
Kraig Biocraft Laboratories Reports Signing Landmark Agreements in South East Asia
April 29, 2024 07:05 ET | Kraig Biocraft Laboratories
Kraig Labs (OTCQB: KBLB) signs key agreements with Lam Dong Agro-Forestry Research Experiment Center for spider silkworm rearing and breeding
Sparbanken Västra Mä
Sparbanken Västra Mälardalen: Delårsrapport 1 januari – 31 mars 2024
April 29, 2024 07:00 ET | Sparbanken Västra Mälardalen
Sparbanken Västra Mälardalen fortsätter att utvecklas positivt och levererar ett mycket starkt och uthålligt resultat under det första kvartalet 2024 trots utmanande tider. Kundens framtid är vårt...
Regeneron Logo.jpg
EYLEA® HD (aflibercept) Injection 8 mg Presentations at ARVO Reinforce Sustained and Clinically Meaningful Outcomes in Serious Retinal Diseases
April 29, 2024 07:00 ET | Regeneron Pharmaceuticals, Inc.
TARRYTOWN, N.Y., April 29, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the presentation of positive long-term results and subgroup analyses from the...
poet-logo@2018.png
POET Announces CAD$10 Million Non-brokered Financing
April 29, 2024 07:00 ET | POET Technologies Inc.
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, April 29, 2024 (GLOBE NEWSWIRE) -- POET Technologies Inc. (“POET” or the “Company”) (TSX Venture:...
aquestive.jpg
Aquestive Therapeutics Receives U.S. FDA Approval and Market Access for Libervant™ (diazepam) Buccal Film in Pediatric Patients Ages 2 to 5 and Provides Update on Anaphylm™ (epinephrine) Sublingual Film
April 29, 2024 07:00 ET | Aquestive Therapeutics, Inc.
Libervant is the first and only FDA approved orally administered rescue product for the treatment of seizure clusters in patients ages 2 to 5Announces immediate availability of Libervant 5mg, 7.5mg,...
CloudMD Logo.png
CloudMD Announces Late Filing of Annual Financial Statements
April 29, 2024 07:00 ET | CloudMD
TORONTO, April 29, 2024 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (TSXV: DOC, OTCQX: DOCRF, Frankfurt: 6PH) (the “Company” or “CloudMD”), an innovative health services company...
The Brainy Insights.png
Bench Hydraulic Press Market Size to Surpass US$21.6 Billion by 2033, The Brainy Insights
April 29, 2024 07:00 ET | The Brainy Insights
Newark, April 29, 2024 (GLOBE NEWSWIRE) -- The Brainy Insights estimates that the USD 13.4 billion bench hydraulic press market will reach USD 21.6 billion by 2033. Due to the increased need for...
Hi ECARX20221221-204233.png
ECARX to Report First Quarter 2024 Financial Results on May 20, 2024
April 29, 2024 07:00 ET | ECARX LIMITED
SHANGHAI, China, April 29, 2024 (GLOBE NEWSWIRE) -- ECARX Holdings, Inc. (Nasdaq: ECX) ("ECARX"), a global mobility tech provider, today announced that it will report its financial results for the...